OrthoPediatrics Corp. (NASDAQ:KIDS) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET

Company Participants

Matt Bacso - IR, Gilmartin Group

David Bailey - President and CEO

Fred Hite - CFO and COO

Conference Call Participants

Matthew O'Brien - Piper Sandler

Samuel Brodovsky - Truist Securities

Mike Matson - Needham & Company

Ryan Zimmerman - BTIG

Dave Turkaly - JMP Securities

Operator

Welcome to the Q1 2022 OrthoPediatrics Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions]

And now would like to turn the call over to Matt Basco. Matt, you may begin.

Matt Bacso

Thank you for joining today's call. With me from the company are David Bailey, President and Chief Executive Officer; and Fred Hite, Chief Operating and Financial Officer.

Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties and the company's actual results may differ materially.

For a discussion of risk factors, including, among others, the risks associated with COVID-19, the impacts this pandemic may have on the demand of the company's products and the company's ability to respond to the related challenges, I encourage you to review the company's most recent annual report on Form 10-K which will be filed with the SEC on march 3rd, 2022.

During the call today, management will also discuss certain non-GAAP financial measures which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period-over-period.

For each non-GAAP financial measure referenced on this call, the company has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in its earnings release.

Please note that the non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for OrthoPediatrics' financial results prepared in accordance with GAAP.

In addition, the content on this call contains time-sensitive information that is accurate only as of the date of this live broadcast, today May 5th, 2022. Except as required by law, the company undertakes no obligation to revise or update any statements to reflect events or circumstances taking place after the date of this call.